Phibro Animal Health Corporation
PAHC
$41.88
-$1.35-3.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.01% | -17.51% | 555.57% | -54.34% | 827.53% |
| Total Depreciation and Amortization | 16.74% | -12.89% | 9.00% | 28.54% | 15.96% |
| Total Amortization of Deferred Charges | -71.30% | 248.43% | 13.49% | 37.33% | -78.36% |
| Total Other Non-Cash Items | -45.22% | 708.36% | -88.05% | 196.92% | -112.09% |
| Change in Net Operating Assets | -135.31% | -269.13% | 147.63% | -1,003.68% | -90.63% |
| Cash from Operations | -56.27% | -50.71% | 1,302.93% | -75.63% | -55.60% |
| Capital Expenditure | -5.05% | -69.66% | 0.97% | 18.38% | 26.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 607.98% | 99.64% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,049.67% | 108.03% | -124.76% | 473.79% | 67.96% |
| Cash from Investing | -198.75% | 61.46% | 92.99% | -8,789.86% | 67.84% |
| Total Debt Issued | 42.08% | -25.27% | -83.16% | -15.17% | 337.52% |
| Total Debt Repaid | 5.56% | 35.91% | 45.89% | 65.94% | -362.53% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.02% | -0.10% | 0.00% | 0.02% |
| Other Financing Activities | -- | 500.39% | 33.42% | 81.26% | -490.26% |
| Cash from Financing | 310.34% | 75.90% | -111.66% | 1,046.40% | -1,733.86% |
| Foreign Exchange rate Adjustments | -91.18% | 102.17% | 116.28% | -605.62% | 201.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.45% | 214.36% | -144.10% | 181.15% | -192.09% |